A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer

被引:0
|
作者
Kumar, Rajiv [1 ]
Lo, Karl [1 ]
Minchom, Anna R. [1 ]
Sharp, Adam [1 ]
Davidson, Michael [1 ]
Gunapala, Ranga [1 ]
Yap, Timothy [2 ,3 ]
Bhosle, Jaishree [1 ]
Popat, Sanjay [1 ]
O'Brien, Mary E. R. [1 ]
机构
[1] Royal Marsden NHS Fdn Trust, Dept Lung Med, London, Surrey, England
[2] Inst Canc Res, Dept Lung Med, London, Surrey, England
[3] Royal Marsden NHS Fdn Trust, London, Surrey, England
关键词
Erlotinib; Capecitabine; Non-small-cell lung cancer; Phase; 1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-077
引用
收藏
页码:S547 / S548
页数:2
相关论文
共 50 条
  • [1] Phase 1b study of capecitabine and erlotinib in advanced non-small cell lung cancer
    Lu, S.
    Popat, S.
    Puglisi, M.
    Kaudeer, N.
    Gennatas, S.
    Hewish, M.
    Ayite, B.
    Bhosle, J.
    O'Brien, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S828 - S828
  • [2] A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
    Rajiv Kumar
    Shir Kiong Lu
    Anna Minchom
    Adam Sharp
    Michael Davidson
    Ranga Gunapala
    Timothy A. Yap
    Jaishree Bhosle
    Sanjay Popat
    Mary E. R. O’Brien
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 77 : 375 - 383
  • [3] A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
    Kumar, Rajiv
    Lu, Shir Kiong
    Minchom, Anna
    Sharp, Adam
    Davidson, Michael
    Gunapala, Ranga
    Yap, Timothy A.
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary E. R.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 375 - 383
  • [4] A phase 1b dose-escalation trial of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer (MCRC) patients.
    Delord, JP
    Beale, P
    Van Cutsem, E
    Clarke, S
    Verslype, C
    Bugat, R
    Rakhit, A
    Fettner, S
    Brennscheidt, U
    Feyereislova, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 266S - 266S
  • [5] Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer
    Vincent, Mark D.
    Breadner, Daniel
    Soulieres, Denis
    Kerr, Ian G.
    Sanatani, Michael
    Kocha, Walter
    Klimo, Peter
    MacKenzie, Mary J.
    O'Connell, Anne
    Whiston, Frances
    Malpage, Anne S.
    Stitt, Larry
    Welch, Stephen A.
    [J]. FUTURE ONCOLOGY, 2017, 13 (09) : 777 - 786
  • [6] A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
    Kathleen N. Moore
    David S. Hong
    Manish R. Patel
    Shubham Pant
    Susanna V. Ulahannan
    Suzanne Jones
    Funda Meric-Bernstam
    Judy S. Wang
    Raid Aljumaily
    Erika P. Hamilton
    Erika S. Wittchen
    Xuejing Wang
    Aimee Bence Lin
    Johanna C. Bendell
    [J]. Targeted Oncology, 2021, 16 : 569 - 589
  • [7] A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
    Moore, Kathleen N.
    Hong, David S.
    Patel, Manish R.
    Pant, Shubham
    Ulahannan, Susanna, V
    Jones, Suzanne
    Meric-Bernstam, Funda
    Wang, Judy S.
    Aljumaily, Raid
    Hamilton, Erika P.
    Wittchen, Erika S.
    Wang, Xuejing
    Lin, Aimee Bence
    Bendell, Johanna C.
    [J]. TARGETED ONCOLOGY, 2021, 16 (05) : 569 - 589
  • [8] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Ravi Paluri
    Ankit Madan
    Peng Li
    Benjamin Jones
    Mansoor Saleh
    Mary Jerome
    Deborah Miley
    Jennifer Keef
    Francisco Robert
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 551 - 559
  • [9] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Paluri, Ravi
    Madan, Ankit
    Li, Peng
    Jones, Benjamin
    Saleh, Mansoor
    Jerome, Mary
    Miley, Deborah
    Keef, Jennifer
    Robert, Francisco
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 551 - 559
  • [10] A PILOT TRIAL OF GEMCITABINE IN COMBINATION WITH CAPECITABINE OR ERLOTINIB COMPARED TO GEMCITABINE ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Cho, J. Y.
    Lim, J. Y.
    Lee, S. J.
    Lee, D. K.
    Park, J. S.
    Yoon, D. S.
    Min, Y. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 240 - 240